We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ramipril Patent Invalid Due To Obviousness: Court

Law360 (September 11, 2007, 12:00 AM EDT) -- An appeals court ruled on Tuesday that King Pharmaceutical's patent on its hypertension drug Altace was obvious and thus invalid, overturning a lower court's ruling that generics maker Lupin LTD infringed...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.